A Study on Safety and Efficacy in Patients With Soft Tissue Sarcomas

NCT03058406 · clinicaltrials.gov ↗

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: Eribulin mesylate

Sponsor

Eisai Co., Ltd.